Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials ; volume:22 ; number:1 ; day:7 ; month:1 ; year:2021 ; pages:1-11 ; date:12.2021
The journal of headache and pain ; 22, Heft 1 (7.1.2021), 1-11, 12.2021
- Classification
-
Medizin, Gesundheit
- Creator
-
Silberstein, Stephen D.
Cohen, Joshua M.
Yang, Ronghua
Gandhi, Sanjay K.
Du, Evelyn
Jann, Adelene E.
Marmura, Michael J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-020-01212-4
- URN
-
urn:nbn:de:101:1-2021020802350519599993
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Silberstein, Stephen D.
- Cohen, Joshua M.
- Yang, Ronghua
- Gandhi, Sanjay K.
- Du, Evelyn
- Jann, Adelene E.
- Marmura, Michael J.
- SpringerLink (Online service)
Other Objects (12)
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis